AI

biotech

FDA Orphan Drug Designation and Rare Pediatric Disease Designation for sarcoma drug

Jim Cornall - October 6, 2026

biotech

Confidence boost for AI virtual cells for novel target discovery

Jim Cornall - October 6, 2026

biotech

Anti-fibrotic drug could be repurposed to control cell communication

Jim Cornall - October 6, 2026

biotech

Positive data from oral therapy designed to improve muscle function and body composition

Jim Cornall - October 5, 2026

AI

Vultures and AI as death detectors

Jim Cornall - November 25, 2024

AI

Applied AI and deeptech innovations take centre stage at Expand North Star 2024

Jim Cornall - October 28, 2024

AI

Cyngn gets patent for autonomous vehicle technology

Jim Cornall - September 11, 2024

AI

New dawn for AI-powered atomic-scale 3D imaging

Jim Cornall - September 3, 2024

AI

Healthy AI: sustainable artificial intelligence for healthcare

Jim Cornall - August 7, 2024

AI

Report shows researchers trust AI, but want transparency

Jim Cornall - July 25, 2024

AI

Watch: Lymbic AI at Hello Tomorrow

Jim Cornall - June 28, 2024

AI

What is swarm computing?

Jim Cornall - June 3, 2024

1...456 7 Page 5 of 7

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

FDA Orphan Drug Designation and Rare Pediatric Disease Designation for sarcoma drug

Jim Cornall - October 6, 2026 0

UTR Therapeutics Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to 3′UTRMYCN M1-14 (UTRxMYCN M1-14)...

Confidence boost for AI virtual cells for novel target discovery

biotech Jim Cornall - October 6, 2026 0

Anti-fibrotic drug could be repurposed to control cell communication

biotech Jim Cornall - October 6, 2026 0

Positive data from oral therapy designed to improve muscle function and body composition

biotech Jim Cornall - October 5, 2026 0

Pneumonia can reveal undiagnosed blood cancer

biotech Jim Cornall - October 5, 2026 0